InvestSMART

Brazilian Critical Minerals Limited (ASX: BCM) - Announcements

Current share price for BCM : $0.051 0.004 (8.51%)+

ASX company news and announcements for Brazilian Critical Minerals Limited (BCM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Brazilian Critical Minerals Limited (BCM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Brazilian Critical Minerals Limited (BCM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Brazilian Critical Minerals Limited (BCM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$100 Placement raises $4.0 Million to advance Ema project 5 Jun 2025 9:35AM $0.010 $0.051 risen by 410%
$100 Trading Halt 3 Jun 2025 9:31AM $0.010 $0.051 risen by 410%
$100 Final Director's Interest Notice - Donovan 29 May 2025 8:19AM $0.010 $0.051 risen by 410%
$100 Initial Director's Interest Notice - Holthouse 29 May 2025 8:19AM $0.010 $0.051 risen by 410%
$100 Board Changes 29 May 2025 8:19AM $0.010 $0.051 risen by 410%
$100 Ema ISR field trial achieves first major permeability hurdle 27 May 2025 8:17AM $0.010 $0.051 risen by 410%
$100 Ema Field Trial Commences 14 May 2025 8:16AM $0.009 $0.051 risen by 466.67%
$100 Results of Meeting 9 May 2025 2:10PM $0.009 $0.051 risen by 466.67%
$100 Notification regarding unquoted securities - BCM 2 May 2025 4:04PM $0.009 $0.051 risen by 466.67%
$100 Quarterly Activities Report 30 Apr 2025 8:15AM $0.009 $0.051 risen by 466.67%
$100 Quarterly Appendix 5B Cash Flow Report 30 Apr 2025 8:14AM $0.009 $0.051 risen by 466.67%
$100 Ema Field Trial receives Magnesium Sulphate Approval 28 Apr 2025 8:21AM $0.009 $0.051 risen by 466.67%
$100 Notice of General Meeting/Proxy Form 3 Apr 2025 3:44PM $0.008 $0.051 risen by 537.50%
$100 Half Yearly Report and Accounts 14 Mar 2025 1:29PM $0.008 $0.051 risen by 537.50%
$100 Ema Project receives Water Permit 13 Mar 2025 8:16AM $0.009 $0.051 risen by 466.67%
$100 Amended Announcement -Ansto ISR Column Permeability 12 Mar 2025 1:23PM $0.009 $0.051 risen by 466.67%
$100 ISR testwork from ANSTO achieves high recoveries 10 Mar 2025 8:22AM $0.009 $0.051 risen by 466.67%
$100 Ema Scoping Study - Investor Presentation 26 Feb 2025 9:38AM $0.010 $0.051 risen by 410%
$100 Ema Rare Earths Scoping Study confirms low CAPEX and OPEX 26 Feb 2025 9:38AM $0.010 $0.051 risen by 410%
$100 Investor Webinar - updated 24 Feb 2025 1:35PM $0.010 $0.051 risen by 410%
$100 Trading Halt 24 Feb 2025 9:08AM $0.010 $0.051 risen by 410%
$100 Investor Webinar 24 Feb 2025 8:10AM $0.010 $0.051 risen by 410%
$100 Ema MRE Delivers Significant Increase in Indicated Resource 21 Feb 2025 8:20AM $0.008 $0.051 risen by 537.50%
$100 Thick Mineralised Intercepts from Ema continues 17 Feb 2025 8:22AM $0.008 $0.051 risen by 537.50%
$100 Notification of cessation of securities - BCM 10 Feb 2025 1:02PM $0.008 $0.051 risen by 537.50%

101 - 125 of 289 results

Page 5 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.